1358O Clinical qualification of transcriptome signatures for advanced prostate cancer (APC) starting androgen deprivation therapy (ADT) with or without abiraterone acetate and prednisolone (AAP): An ancillary study of the STAMPEDE AAP trial

Autor: M. Parry, E. Grist, C. Brawley, J.A. Proudfoot, L. Mendes, S. Lall, A.P. Hoyle, A. Sachdeva, Y. Liu, C. Amos, M.R. Sydes, R. Jones, M.K. Parmar, F. Feng, C.J. Sweeney, N. Clarke, E. Davicioni, N.D. James, null L. Brown, G. Attard
Rok vydání: 2022
Předmět:
Zdroj: Annals of Oncology. 33:S1161
ISSN: 0923-7534
DOI: 10.1016/j.annonc.2022.07.1491
Databáze: OpenAIRE